Detection and quantification of sample contamination in immune repertoire analysis

Patent metadata

Field	Value
Publication number	US-9394567-B2
Application number	US-201313859210-A
Country	US
Kind code	B2
Filing date	Apr 9, 2013
Priority date	Nov 7, 2008
Publication date	Jul 19, 2016
Grant date	Jul 19, 2016

Abstract

The invention is directed to methods for detecting and quantifying nucleic acid contamination in a tissue sample of an individual containing T cells and/or B cells, which is used for generating a sequence-based clonotype profile. In one aspect, the invention is implemented by measuring the presence and/or level of an endogenous or exogenous nucleic acid tag by which nucleic acid from an intended individual can be distinguished from that of unintended individuals. Endogenous tags include genetic identity markers, such as short tandem repeats, rare clonotypes or the like, and exogenous tags include sequence tags employed to determine clonotype sequences from sequence reads.

First claim

What is claimed is:

1. A method of determining carry over contamination in a sample containing T cells and/or B cells in vitro, comprising:
determining a clonotype profile for each of a plurality of samples by the following steps:
(i) attaching sequence tags to molecules of recombined nucleic acids of T-cell receptor genes or immunoglobulin genes of the T-cells and/or B-cells to form tag-molecule conjugates, wherein substantially every molecule of the tag-molecule conjugates has a unique sequence tag;
(ii) amplifying the tag-molecule conjugates;
(iii) sequencing the tag-molecule conjugates to produce sequence reads that each comprise a sequence tag portion and a clonotype portion; and
(iv) aligning like sequence tag portions of the sequence reads to determine a clonotype sequence from corresponding clonotype portions of the aligned sequence reads and generating a clonotype profile from the clonotype portions; and

recording nucleotide sequences of the sequence tags of each measurement of a clonotype profile; and
determining carry over contamination in the sample by the presence, absence and/or level of sequence tags from any clonotype profile of said plurality of samples.

2. The method of claim 1 , wherein said step of aligning further includes determining the nucleotide sequence of each of said clonotype of each of said tag-molecule conjugate by determining a majority nucleotide at each nucleotide position of said clonotypes of said like sequence tag portions.

3. The method of claim 1 , wherein said step of attaching includes labeling by sampling said molecules of recombined nucleic acids.

4. The method of claim 3 , wherein said step of attaching is implemented in a reaction mixture such that said sequence tags are present in the reaction mixture in a concentration at least 100 times that of said molecules of recombined nucleic acids.

5. The method of claim 4 , wherein said sequence tags are incorporated into primers specific for said molecules of recombined nucleic acids.

6. The method of claim 1 , wherein said clonotypes are each 25 to 400 nucleotides in length encoding a segment of an immune receptor or immune receptor component selected from the group consisting of a VDJ rearrangement of IgH, a DJ rearrangement of IgH, a VJ rearrangement of IgK, a VJ rearrangement of IgL, a VDJ rearrangement of TCR β, a DJ rearrangement of TCR β, a VJ rearrangement of TCR α, a VJ rearrangement of TCR γ, a VDJ rearrangement of TCR δ, and a VD rearrangement of TCR δ.

7. The method of claim 1 , wherein determining carry over contamination comprises measuring the presence, absence, and/or level of sequence tags from any prior clonotype profile and comparing such against a subsequent clonotype profile.

8. The method of claim 1 , wherein the presence of a unique sequence tag shared amongst said any clonotype profile of said plurality of samples indicates a carry over contamination event.

Assignees

• Sequenta Inc
• Adaptive Biotechnologies Corp

Inventors

• Asbury Thomas
• Carlton Victoria
• Faham Malek
• Macevicz Stephen C
• Moorhead Martin
• Willis Thomas
• Zheng Jianbiao

Classifications

• C12Q2600/158

  Expression markers · CPC title

• C12Q1/6869

  Methods for sequencing · CPC title

• C12Q1/6883 Primary

  for diseases caused by alterations of genetic material · CPC title

• C12Q2537/143

  Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis · CPC title

• C12Q2525/191

  incorporating an adaptor · CPC title